2004年11月20日 · Japanese, born 1940

Koichi Yoshimura's 82 research works with 2,307 citations and 7,029 reads, including: A Novel Hybrid Drug Delivery System for Treatment of Aortic Aneurysms

2020年8月2日 · Ongoing aortic wall degeneration and subsequent aneurysm exclusion failure are major concerns after an endovascular aneurysm repair with a stent-graft. An ideal solution would be a drug therapy that targets the aortic wall and inhibits wall degeneration.

Koichi Yoshimura's 28 research works with 415 citations and 4,103 reads, including: Age-Related Changes in Total Corneal Astigmatism in Eyes With High Myopia

With a keen focus on business development, Koichi Yoshimura channels his proficiency in the art of facilitation to supporting projects for leading manufacturers, insurance companies, system integration vendors and other clients.

Context: Although methimazole (MMI) and propylthiouracil (PTU) have long been used to treat hyperthyroidism caused by Graves' disease (GD), there is still no clear conclusion about the choice of drug or appropriate initial doses.

View the profiles of people named Yoshimura Koichi. Join Facebook to connect with Yoshimura Koichi and others you may know. Facebook gives people the...

Koichi YOSHIMURA | Director | Research profile. Home. Koichi Yoshimura. Marubeni Infrastructure Investments Australia Pty Ltd. Contact. Connect with experts in your field. Join ResearchGate...

Loop is the open research network that increases the discoverability and impact of researchers and their work. Loop enables you to stay up-to-date with the latest discoveries and news, connect with researchers and form new collaborations.